NCT05663346

Brief Summary

The purpose of this study is to evaluate the preliminary effects and impacts of a digital educational intervention to support nurses' professional practice regarding safe cannabis use by young adults (18-39 years) diagnosed with cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 23, 2022

Completed
1 year until next milestone

Study Start

First participant enrolled

January 4, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2024

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

2 months

First QC Date

December 15, 2022

Last Update Submit

February 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in self-efficacy

    The French version of the Continuing Professional Development Reaction (CPD-Reaction) questionnaire (Légaré et al., 2014) will be used. The CPD-Reaction is a 12-item theory-based self-report questionnaire designed to assess the impact of continuing professional development on different clinical practices and can be modified according to the behavior targeted by the continuing professional activity (ie, the Cannabis \& Cancer intervention). It is scored using a seven-point Likert scale ranging from strongly disagree (1) to strongly agree (7). The total score can range from 3 to 21 for self-efficacy. Higher scores indicate higher levels of self-efficacy. The CPD Reaction has adequate test-retest reliability (ie, weighted kappa coefficient between 0.43-0.53 for self-efficacy). The questionnaire has good internal consistency (Cronbach's alpha = 0.84).

    4 weeks

Secondary Outcomes (8)

  • Change in attitudes

    4 weeks

  • Change in intention

    4 weeks

  • Change in knowledge

    4 weeks

  • Number of training modules completed by participants (objective engagement)

    4 weeks

  • Frequency of viewing modules/participants (objective engagement)

    4 weeks

  • +3 more secondary outcomes

Study Arms (2)

Cannabis & Cancer digital educational intervention

EXPERIMENTAL

This intervention includes different asynchronous pedagogical modalities that allow, among other things, to reactivate the participants' previous knowledge and promote their autonomy in their learning process. These modalities focus on various problems that oncology nurses may encounter about the use of cannabis in oncology (eg, how to tackle the subject, what are the correct times to approach the topic). To this end, various pedagogical modalities that encourage the active participation of nurses are integrated into the training (eg, interactive videos, and quizzes). Scientific articles and links to external resources (official public websites) are also included so that nurses can consult the content at their own pace. Different aspects related to the use of cannabis are addressed in the training (eg, beneficial effects, and potential side effects).

Other: Cannabis & Cancer digital educational intervention

Standard information regarding cannabis use in oncology

ACTIVE COMPARATOR

The comparator is composed of an email with basic reliable non-personalized information on cannabis use in oncology (official public websites and scientific articles).

Other: Standard information regarding cannabis use in oncology

Interventions

The Cannabis \& Cancer intervention is available on Moodle learning management system in French language. It aims to influence nurses' self-efficacy, attitudes, intentions, and knowledge regarding the safe and efficient use of cannabis by young adults diagnosed with cancer.

Cannabis & Cancer digital educational intervention

Participants will be offered basic reliable non-personalized information on cannabis use in oncology (official public websites and scientific articles).

Standard information regarding cannabis use in oncology

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Work in an oncology department (eg, radio-oncology, outpatient clinics)
  • Work with people diagnosed with cancer, including young adults
  • Understand, read, and write French

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Maisonneuve-Rosemont

Montreal, Quebec, H1T 2M4, Canada

Location

Related Publications (1)

  • Vinette B, Cote J, Bilodeau K. Evaluation of a Digital Educational Intervention to Enhance Oncology Nurse Professional Practice to Support Safe Cannabis Use: A Pilot Study. J Contin Educ Health Prof. 2025 Dec 17. doi: 10.1097/CEH.0000000000000631. Online ahead of print.

MeSH Terms

Conditions

Cancer PainSigns and Symptoms

Interventions

nabiximols

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsPathological Conditions, Signs and Symptoms

Study Officials

  • Karine Bilodeau, PhD

    Université de Montréal

    PRINCIPAL INVESTIGATOR
  • José Côté

    Université de Montréal

    PRINCIPAL INVESTIGATOR
  • Billy Vinette, MSN

    Univer

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2022

First Posted

December 23, 2022

Study Start

January 4, 2024

Primary Completion

March 18, 2024

Study Completion

May 18, 2024

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations